Salonen M, Aaltonen L, Aantaa E, Kanto J
Acta Pharmacol Toxicol (Copenh). 1986 Oct;59(4):303-5. doi: 10.1111/j.1600-0773.1986.tb00173.x.
Saccadic eye movements and the subjective assessments of the volunteers were used in the determination of the residual effects of a single evening dose of flunitrazepam 0.5 mg, 1 mg and 2 mg or placebo. Sleep inducing and maintaining effects were subjectively assessed, too. Flunitrazepam at all three dose levels possessed sleep inducing and increasing effects (n = 9), but in the number of nocturnal awakenings and sedation in the morning (10 hrs after drug intake), no significant differences between placebo and the active medications were reported. However, saccadic eye movement recording could differentiate the residual effects produced by placebo or the active medication. No correlation was detected between the serum levels (radioreceptor assay) and saccadic eye movement recordings.
采用志愿者的眼球跳动和主观评估来确定单剂0.5毫克、1毫克和2毫克氟硝西泮或安慰剂在夜间的残留效应。同时也对睡眠诱导和维持效果进行了主观评估。所有三个剂量水平的氟硝西泮均具有诱导睡眠和增强睡眠的作用(n = 9),但在夜间觉醒次数和早晨(服药后10小时)的镇静作用方面,安慰剂与活性药物之间未报告有显著差异。然而,眼球跳动记录能够区分安慰剂或活性药物产生的残留效应。在血清水平(放射受体测定)与眼球跳动记录之间未检测到相关性。